<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Dimethyllysergamide</id>
	<title>Dimethyllysergamide - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Dimethyllysergamide"/>
	<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Dimethyllysergamide&amp;action=history"/>
	<updated>2026-05-12T20:37:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.1</generator>
	<entry>
		<id>http://debianws.lexgopc.com/wiki143/index.php?title=Dimethyllysergamide&amp;diff=3182742&amp;oldid=prev</id>
		<title>imported&gt;AlyInWikiWonderland: See also.</title>
		<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Dimethyllysergamide&amp;diff=3182742&amp;oldid=prev"/>
		<updated>2025-06-29T21:20:37Z</updated>

		<summary type="html">&lt;p&gt;See also.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{short description|Chemical compound}}&lt;br /&gt;
{{cs1 config|name-list-style=vanc|display-authors=6}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Watchedfields = changed&lt;br /&gt;
| verifiedrevid = 447574383&lt;br /&gt;
| image = DAM-57.svg&lt;br /&gt;
| width = 165px&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| legal_AU =  &lt;br /&gt;
| legal_CA =  &lt;br /&gt;
| legal_UK =  &lt;br /&gt;
| legal_US = Schedule I&lt;br /&gt;
| legal_US_comment = Controlled in the United States via the [[Federal Analog Act]] but only if it is intended for human consumption.&lt;br /&gt;
| routes_of_administration = [[Wiktionary:oral|Oral]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| metabolism = hepatic&lt;br /&gt;
| excretion = renal&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| PubChem = 199478&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 172668&lt;br /&gt;
| CAS_number = 4238-84-0&lt;br /&gt;
| CAS_number_Ref = {{Cascite|correct|CAS}}&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = LX5MKR2EXX&lt;br /&gt;
| synonyms = DAM-57; &amp;#039;&amp;#039;N&amp;#039;&amp;#039;,&amp;#039;&amp;#039;N&amp;#039;&amp;#039;-Dimethyllysergamide; DAM; Lysergic acid dimethylamide&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| IUPAC_name = (6a&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,9&amp;#039;&amp;#039;R&amp;#039;&amp;#039;)-&amp;#039;&amp;#039;N&amp;#039;&amp;#039;,&amp;#039;&amp;#039;N&amp;#039;&amp;#039;-dimethyl-7-methyl-4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9-carboxamide&lt;br /&gt;
| C=18 | H=21 | N=3 | O=1 &lt;br /&gt;
| SMILES = O=C(N(C)C)[C@@H]3C=C2c4cccc1c4c(c[nH]1)C[C@H]2N(C3)C&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C18H21N3O/c1-20(2)18(22)12-7-14-13-5-4-6-15-17(13)11(9-19-15)8-16(14)21(3)10-12/h4-7,9,12,16,19H,8,10H2,1-3H3/t12-,16-/m1/s1&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChIKey = FWHSERNVTGTIJE-MLGOLLRUSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DAM-57&amp;#039;&amp;#039;&amp;#039;, also known as &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;N&amp;#039;&amp;#039;,&amp;#039;&amp;#039;N&amp;#039;&amp;#039;-dimethyllysergamide&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;DAM&amp;#039;&amp;#039;&amp;#039;) or as &amp;#039;&amp;#039;&amp;#039;lysergic acid dimethylamide&amp;#039;&amp;#039;&amp;#039;, is a [[Derivative (chemistry)|derivative]] of [[ergine]]. There has been a single report of observing N,N-dimethyl-D-lysergamide in the illicit drug market.&amp;lt;ref&amp;gt;{{cite journal | vauthors = Clark AB | title = Lysergic Acid Diethylamide and Lysergic Acid Dimethylamide | journal = Microgram | volume = 6 | pages = 37 | date = 1973 }}&amp;lt;/ref&amp;gt; This compound did induce autonomic disturbances at oral levels of some ten times the dosage required for [[lysergic acid diethylamide]] (LSD), presumably in the high hundreds of micrograms. There is some disagreement as to whether there were psychic changes observed.&amp;lt;ref&amp;gt;{{CiteTiHKAL | pages = 26 }}; {{cite web | title = #26. LSD-25 | url = https://www.erowid.org/library/books_online/tihkal/tihkal26.shtml | work = Erowid }}&amp;lt;/ref&amp;gt; It was first described in the [[scientific literature]] by [[Albert Hofmann]] and colleagues by 1955.&amp;lt;ref name=&amp;quot;Hofmann_1955&amp;quot;&amp;gt;{{cite journal | vauthors = Hofmann A, Stoll A | title = Amide der stereoisomeren Lysergsäuren und Dihydro‐lysergsäuren. 38. Mitteilung über Mutterkornalkaloide | journal = Helvetica Chimica Acta | volume = 38 | issue = 2 | pages = 421–433 | date = 1955 | doi = 10.1002/hlca.19550380207 | trans-title = Amides of stereoisomeric lysergic and dihydrolysergic acids. 38. Ergot alkaloids | issn = 0018-019X | url = https://onlinelibrary.wiley.com/doi/10.1002/hlca.19550380207 | access-date = 5 June 2025 | url-access = subscription }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[Substituted lysergamide]]&lt;br /&gt;
* [[Lysergic acid methylamide]] (LAM)&lt;br /&gt;
* [[Lysergic acid dipropylamide]] (DPL)&lt;br /&gt;
* [[Lysergic acid diallylamide]] (DAL)&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Psychedelics}}&lt;br /&gt;
{{Ergolines}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Designer drugs]]&lt;br /&gt;
[[Category:Psychedelic lysergamides]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Hallucinogen-stub}}&lt;/div&gt;</summary>
		<author><name>imported&gt;AlyInWikiWonderland</name></author>
	</entry>
</feed>